🔎 Trials Near Me

Home › Sepsis › Pennsylvania

Sepsis clinical trials in Pennsylvania

8 studies for Sepsis are looking for participants at sites in Pennsylvania.

Cities in Pennsylvania

A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.

  • Research Site, Philadelphia
  • Research Site, Pittsburgh
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07215702

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

  • Research Site, Bethlehem
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Aug 14, 2026 · NCT06749457

Vancomycin and Acute Kidney Injury in Sepsis Treatment - Intervention

  • Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 1
1 Month – 17 Years · All sexes · Updated May 18, 2026 · NCT07084129

Safe and Explainable AI

  • Hospital of the University of Pennsylvania, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 25, 2026 · NCT06694181

The APS Phenotyping Study

  • University of Pennsylvania, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 20, 2026 · NCT06521502

External Drainage of Thoracic Duct Lymph to Reduce Inflammatory Cytokines in Septic Shock Patients

  • Hospital of the University of Pennsylvania, Philadelphia
Recruiting
Ages 18 to 80 · All sexes · Updated Feb 18, 2026 · NCT04855786

Stress Hydrocortisone In Pediatric Septic Shock

  • Penn State Milton S. Hershey Children's Hospital, Hershey
RecruitingPhase 3
1 Month – 17 Years · All sexes · Updated Oct 30, 2025 · NCT03401398

Reducing Empiric VAncomycin Use in Pediatric Suspected Sepsis

  • Children's Hospital of Philadelphia, Philadelphia
Recruiting
All ages · All sexes · Updated Sep 19, 2025 · NCT05975671

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.